🧵 1. British startup unveils AI platform analyzing MRI scans for early disease detection, using imaging biomarkers. Improves decision-making in diagnosis and treatment. #tech
🧵 1. British startup unveils AI platform analyzing MRI scans for early disease detection, using imaging biomarkers. Improves decision-making in diagnosis and treatment. #tech
🧵 2. Twinn Health, backed by $500 million venture capital fund from Saudi Aramco, focuses on longevity and preventive healthcare. Aims to pioneer new era of disease management.
🧵 3. Traditional MRI scans focus on single diagnosis, with little follow-up. Twinn Health aims to extract additional insights, augmenting physicians' findings.
🧵 4. Twinn Health combines AI and MRI technologies to detect and manage age-associated diseases, targeting age-related frailty and liver disease. Ambitious roadmap ahead.
🧵 5. Primary focus on metabolic disease: diabetes, high blood pressure, obesity. AI platform scans MRI images for hidden fatty deposits, crucial heart disease indicator. Promising early trials.
🧵 Read more at: https://decrypt.co/150591/ai-mri-scan-disease-detection-longevity